Literature DB >> 10926758

VEGF regulates cell behavior during vasculogenesis.

C J Drake1, A LaRue, N Ferrara, C D Little.   

Abstract

Prominent among molecules that control neovascular processes is vascular endothelial growth factor (VEGF). The VEGF ligands comprise a family of well-studied mitogens/permeability factors that bind cell surface receptor tyrosine kinases. Targets include VEGF receptor-1/Flt1 and VEGF receptor-2/Flk1. Mice lacking genes for VEGF ligand or VEGF receptor-2 die early in gestation, making it difficult to determine the precise nature of underlying endothelial cellular behavior(s). To examine the effect(s) of VEGF signaling on cell behavior in detail, we conducted loss-of-function studies using avian embryos. Injection of soluble VEGFR-1 results in malformed vascular networks and the absence of large vessels. In the most severe cases embryos exhibited vascular atresia. Closely associated with the altered phenotype was a clear endothelial cell response-a marked decrease in cell protrusive activity. Further, we demonstrate that VEGF gain of function strikingly increased cell protrusive activity. Together, our data show that VEGF/VEGF receptor signaling regulates endothelial cell protrusive activity, a key determinant of blood vessel morphogenesis. We propose that VEGF functions as an instructive molecule during de novo blood vessel morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926758     DOI: 10.1006/dbio.2000.9744

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  27 in total

Review 1.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

2.  Spatial coordination between cell and nuclear shape within micropatterned endothelial cells.

Authors:  Marie Versaevel; Thomas Grevesse; Sylvain Gabriele
Journal:  Nat Commun       Date:  2012-02-14       Impact factor: 14.919

3.  Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling.

Authors:  Roeland M H Merks; Sergey V Brodsky; Michael S Goligorksy; Stuart A Newman; James A Glazier
Journal:  Dev Biol       Date:  2005-12-01       Impact factor: 3.582

4.  Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation.

Authors:  Ke Xu; Diana C Chong; Scott A Rankin; Aaron M Zorn; Ondine Cleaver
Journal:  Dev Biol       Date:  2009-03-06       Impact factor: 3.582

5.  Embryonic vasculogenesis and hematopoietic specification.

Authors:  Lauren C Goldie; Melissa K Nix; Karen K Hirschi
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

6.  Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis.

Authors:  Kelley M Argraves; Brent A Wilkerson; W Scott Argraves
Journal:  World J Biol Chem       Date:  2010-10-26

7.  Engineered human myocardium with local release of angiogenic proteins improves vascularization and cardiac function in injured rat hearts.

Authors:  Fabiola Munarin; Rajeev J Kant; Cassady E Rupert; Amelia Khoo; Kareen L K Coulombe
Journal:  Biomaterials       Date:  2020-04-12       Impact factor: 12.479

8.  Rapid remodeling of airway vascular architecture at birth.

Authors:  Amy Ni; Erin Lashnits; Li-Chin Yao; Peter Baluk; Donald M McDonald
Journal:  Dev Dyn       Date:  2010-09       Impact factor: 3.780

9.  Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity.

Authors:  Anjali Verma; Resham Bhattacharya; Indu Remadevi; Keguo Li; Kallal Pramanik; Ganesh V Samant; Mark Horswill; Chang Z Chun; Baofeng Zhao; Enfeng Wang; Robert Qing Miao; Debabrata Mukhopadhyay; Ramani Ramchandran; George A Wilkinson
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

10.  In Vitro Multitissue Interface Model Supports Rapid Vasculogenesis and Mechanistic Study of Vascularization across Tissue Compartments.

Authors:  Kevin P Buno; Xuemei Chen; Justin A Weibel; Stephanie N Thiede; Suresh V Garimella; Mervin C Yoder; Sherry L Voytik-Harbin
Journal:  ACS Appl Mater Interfaces       Date:  2016-05-02       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.